Back to homepage

Tag "dgci"

Corbevax gets EUA for children aged 5-12 years

Corbevax gets EUA for children aged 5-12 years

🕔06:54, 27.Apr 2022

Vaccine maker Biological E. Ltd on Tuesday announced that its Covid-19 vaccine Corbevax has received a nod from the Drugs Controller General of India (DCGI) for emergency use authorisation for the 5-12-year age group. Hyderabad, April 27 (IANS) Vaccine maker Biological

Read Full Article
DCGI grants EUA to 3 Covid vaccines for different age group of children

DCGI grants EUA to 3 Covid vaccines for different age group of children

🕔16:48, 26.Apr 2022

The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for children of different age groups. New Delhi, April 26 (IANS) The Drugs Controller General of India (DCGI) on Tuesday approved

Read Full Article
DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster

DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster

🕔13:15, 5.Jan 2022

New Delhi, Jan 5 (IANS) The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted “in principle” approval to Bharat Biotech to conduct “Phase III superiority study and Phase III booster dose study” trials for

Read Full Article
Zydus Cadila seeks DCGI approval for oral pill to treat anemia

Zydus Cadila seeks DCGI approval for oral pill to treat anemia

🕔07:26, 24.Nov 2021

New Delhi, Nov 24 (IANS) Pharma major Zydus Cadila has sought approval from the Drug Controller General of India, the apex drug regulator, for a new drug named Desidustat. Desidustat is an oral alternative to injectable erythropoietin-stimulating agents (ESAs) for the

Read Full Article
SII seeks regular marketing authorisation for Covishield from DCGI

SII seeks regular marketing authorisation for Covishield from DCGI

🕔07:23, 26.Oct 2021

New Delhi, Oct 26 (IANS) Serum Institute of India (SII) on Monday sought regular marketing authorisation for Covid vaccine, Covishield from Drugs Controller General of India (DCGI). The application sent to the DCGI said that SII has already submitted phase-3 clinical

Read Full Article
Sputnik’s single-dose vax gets DCGI nod for Phase-III trials in India

Sputnik’s single-dose vax gets DCGI nod for Phase-III trials in India

🕔15:35, 15.Sep 2021

New Delhi, Sep 15  The Drugs Controller General of India (DCGI) has granted permission for the conducting of the Phase III bridging trials of Sputnik Light on the Indian population. The Sputnik Light is a single-dose Covid-19 vaccine of the

Read Full Article
DCGI finds first mRNA vaccine safe, gives nods for Phase 2/3 trials

DCGI finds first mRNA vaccine safe, gives nods for Phase 2/3 trials

🕔22:06, 27.Aug 2021

New Delhi, Aug 27  The Drug Controller General of India has approved the Phase 2 and 3 clinical trials of India’s first Covid-19 mRNA vaccine. Pune-based pharma major Gennova Biopharmaceuticals Ltd is developing the nation’s first mRNA-based Covid-19 vaccine. It

Read Full Article
‘Covaxin for children may get DGCI nod before trial period’

‘Covaxin for children may get DGCI nod before trial period’

🕔06:53, 23.Aug 2021

Bengaluru, Aug 23  The Central government and the Drugs Controller General of India (DCGI) may give approval to the Covaxin vaccines for children soon for emergency use, sources said. The administration of two doses of vaccination has been completed among

Read Full Article
DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old

DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old

🕔12:30, 13.May 2021

New Delhi, May 13 The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health

Read Full Article
Centre disapproves administration of Covaxin to those below 18 yrs

Centre disapproves administration of Covaxin to those below 18 yrs

🕔05:37, 15.Jan 2021

New Delhi, Jan 15  In a major shift of narrative, the government has now disapproved the authorisation of Bharat Biotech’s Covid vaccine to people below 18 years of age whereas earlier, it was approved for children above the age of

Read Full Article
Vaccine: DCGI panel to meet Bharat Biotech officials shortly

Vaccine: DCGI panel to meet Bharat Biotech officials shortly

🕔13:09, 2.Jan 2021

New Delhi, Jan 2  A committee of experts assessing the coronavirus vaccines has called Hyderabad-based Bharat Biotech for a meeting at 1.30 pm on Saturday, a day after the firm was asked to present more data on its ‘Covaxin’ to

Read Full Article
Zenara Pharma gets approval to manufacture, sell Favipiravir

Zenara Pharma gets approval to manufacture, sell Favipiravir

🕔16:53, 5.Aug 2020

Hyderabad, Aug 5  Hyderabad-based Zenara Pharma on Wednesday announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and sell Favipiravir tablets as a treatment option for patients with mild to moderate symptoms of

Read Full Article